Mission Creek Capital Partners’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
NVPX
NVPX
Mission Creek Capital Partners's HCAT Position: Q2 2020 in Review
Mission Creek Capital Partners sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 42,137 shares — an estimated $1.1M sold.
Mission Creek Capital Partners first reported a position in HCAT in Q1 2020 and held it in 1 quarter. The position peaked at $1.1M in Q1 2020. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.
- Mission Creek Capital Partners reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
- Mission Creek Capital Partners sold 42,137 Health Catalyst shares in Q2 2020, an estimated $1.1M.
- Mission Creek Capital Partners first reported a position in Health Catalyst in Q1 2020 and held it in 1 quarter.
- Mission Creek Capital Partners's Health Catalyst position peaked at $1.1M in Q1 2020.
- 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.
Based on Mission Creek Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.